Orbimed Advisors as of Dec. 31, 2016
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 129 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 5.4 | $427M | 3.5M | 122.35 | |
| Biogen Idec (BIIB) | 4.6 | $363M | 1.3M | 283.58 | |
| Celgene Corporation | 4.6 | $360M | 3.1M | 115.75 | |
| Boston Scientific Corporation (BSX) | 4.5 | $357M | 17M | 21.63 | |
| Amgen (AMGN) | 4.3 | $341M | 2.3M | 146.21 | |
| Merck & Co (MRK) | 3.5 | $272M | 4.6M | 58.87 | |
| Eli Lilly & Co. (LLY) | 2.7 | $213M | 2.9M | 73.55 | |
| Incyte Corporation (INCY) | 2.7 | $209M | 2.1M | 100.27 | |
| Shire | 2.6 | $205M | 1.2M | 170.38 | |
| Humana (HUM) | 2.4 | $191M | 936k | 204.03 | |
| Abbvie (ABBV) | 2.3 | $183M | 2.9M | 62.62 | |
| Wright Medical Group Nv | 2.2 | $174M | 7.6M | 22.98 | |
| Pfizer (PFE) | 2.1 | $168M | 5.2M | 32.48 | |
| Agilent Technologies Inc C ommon (A) | 2.1 | $165M | 3.6M | 45.56 | |
| Allergan | 2.1 | $162M | 770k | 210.01 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $159M | 2.2M | 73.67 | |
| Hca Holdings (HCA) | 1.9 | $148M | 2.0M | 74.02 | |
| Anthem (ELV) | 1.9 | $147M | 1.0M | 143.77 | |
| Array BioPharma | 1.8 | $141M | 16M | 8.79 | |
| Regeneron Pharmaceuticals (REGN) | 1.7 | $130M | 355k | 367.09 | |
| Edwards Lifesciences (EW) | 1.6 | $127M | 1.4M | 93.70 | |
| Intercept Pharmaceuticals In | 1.6 | $122M | 1.1M | 108.65 | |
| Thermo Fisher Scientific (TMO) | 1.4 | $113M | 800k | 141.10 | |
| Synergy Pharmaceuticals | 1.4 | $111M | 18M | 6.09 | |
| Ironwood Pharmaceuticals (IRWD) | 1.4 | $111M | 7.2M | 15.29 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $106M | 1.3M | 82.84 | |
| Aetna | 1.3 | $100M | 806k | 124.01 | |
| Johnson & Johnson (JNJ) | 1.3 | $99M | 858k | 115.21 | |
| Intuitive Surgical (ISRG) | 1.2 | $92M | 146k | 634.17 | |
| Audentes Therapeutics | 1.1 | $88M | 4.8M | 18.27 | |
| Bristol Myers Squibb (BMY) | 1.1 | $87M | 1.5M | 58.44 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $82M | 2.1M | 38.70 | |
| Corvus Pharmaceuticals (CRVS) | 1.0 | $77M | 5.4M | 14.30 | |
| Gilead Sciences (GILD) | 1.0 | $76M | 1.1M | 71.61 | |
| Glaukos (GKOS) | 0.9 | $75M | 2.2M | 34.30 | |
| Mallinckrodt Pub | 0.9 | $73M | 1.5M | 49.82 | |
| Insmed (INSM) | 0.9 | $70M | 5.3M | 13.23 | |
| Puma Biotechnology (PBYI) | 0.9 | $70M | 2.3M | 30.70 | |
| Allergan Plc pfd conv ser a | 0.9 | $67M | 88k | 762.46 | |
| Magellan Health Services | 0.8 | $60M | 802k | 75.25 | |
| Aerie Pharmaceuticals | 0.7 | $57M | 1.5M | 37.85 | |
| Insys Therapeutics | 0.7 | $56M | 6.1M | 9.20 | |
| Loxo Oncology | 0.7 | $56M | 1.7M | 32.12 | |
| Tenet Healthcare Corporation (THC) | 0.7 | $55M | 3.7M | 14.84 | |
| Medtronic (MDT) | 0.7 | $55M | 767k | 71.23 | |
| Ascendis Pharma A S (ASND) | 0.7 | $55M | 2.7M | 20.24 | |
| Achillion Pharmaceuticals | 0.7 | $54M | 13M | 4.13 | |
| Eagle Pharmaceuticals (EGRX) | 0.7 | $53M | 671k | 79.34 | |
| UnitedHealth (UNH) | 0.6 | $47M | 296k | 160.04 | |
| Momenta Pharmaceuticals | 0.6 | $44M | 3.0M | 15.05 | |
| Cooper Companies | 0.6 | $44M | 250k | 174.93 | |
| Gw Pharmaceuticals Plc ads | 0.6 | $44M | 397k | 111.75 | |
| Jazz Pharmaceuticals (JAZZ) | 0.5 | $41M | 371k | 109.03 | |
| Stryker Corporation (SYK) | 0.5 | $38M | 316k | 119.81 | |
| Intellia Therapeutics (NTLA) | 0.4 | $35M | 2.7M | 13.11 | |
| Selecta Biosciences | 0.4 | $32M | 1.8M | 17.15 | |
| Immunomedics Inc note 4.750% 2/1 | 0.4 | $30M | 30M | 0.99 | |
| Otonomy | 0.4 | $29M | 1.9M | 15.90 | |
| Viewray (VRAYQ) | 0.4 | $29M | 9.1M | 3.13 | |
| Beigene (ONC) | 0.3 | $27M | 904k | 30.36 | |
| Molina Healthcare (MOH) | 0.3 | $27M | 496k | 54.26 | |
| Illumina (ILMN) | 0.3 | $23M | 182k | 128.04 | |
| Lion Biotechnologies | 0.3 | $24M | 3.4M | 6.95 | |
| Coherus Biosciences (CHRS) | 0.3 | $24M | 850k | 28.15 | |
| Dimension Therapeutics | 0.3 | $24M | 5.4M | 4.35 | |
| Teva Pharmaceutical Industries (TEVA) | 0.3 | $22M | 615k | 36.25 | |
| Xencor (XNCR) | 0.3 | $22M | 840k | 26.32 | |
| Newlink Genetics Corporation | 0.3 | $21M | 2.0M | 10.28 | |
| eHealth (EHTH) | 0.2 | $19M | 1.8M | 10.65 | |
| Galapagos Nv- (GLPG) | 0.2 | $18M | 284k | 64.19 | |
| Bluebird Bio | 0.2 | $18M | 284k | 61.70 | |
| Assembly Biosciences | 0.2 | $17M | 1.4M | 12.15 | |
| Sinovac Biotech | 0.2 | $16M | 2.7M | 5.90 | |
| Natera (NTRA) | 0.2 | $15M | 1.3M | 11.71 | |
| Immunomedics | 0.2 | $14M | 3.8M | 3.67 | |
| C.R. Bard | 0.2 | $13M | 58k | 224.66 | |
| ImmunoGen | 0.2 | $12M | 6.1M | 2.04 | |
| EXACT Sciences Corporation (EXAS) | 0.2 | $13M | 950k | 13.36 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $13M | 1.7M | 7.28 | |
| Portola Pharmaceuticals | 0.2 | $12M | 552k | 22.44 | |
| Dermira | 0.2 | $13M | 426k | 30.33 | |
| Vanda Pharmaceuticals (VNDA) | 0.1 | $12M | 750k | 15.95 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $12M | 169k | 70.31 | |
| Forward Pharma A/s | 0.1 | $12M | 798k | 15.00 | |
| Dbv Technologies S A | 0.1 | $12M | 346k | 35.13 | |
| Select Medical Holdings Corporation (SEM) | 0.1 | $11M | 832k | 13.25 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $11M | 2.3M | 4.90 | |
| Inotek Pharmaceuticals | 0.1 | $11M | 1.8M | 6.10 | |
| Pieris Pharmaceuticals | 0.1 | $10M | 7.3M | 1.41 | |
| Nabriva Therapeutics | 0.1 | $10M | 1.7M | 5.96 | |
| Abbott Laboratories (ABT) | 0.1 | $9.4M | 245k | 38.41 | |
| NuVasive | 0.1 | $8.3M | 124k | 67.36 | |
| Incyte Corp. note 1.250 11/1 | 0.1 | $8.7M | 4.3M | 2.04 | |
| Incyte Corp note 0.375%11/1 | 0.1 | $8.5M | 4.3M | 2.00 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $7.7M | 1.0M | 7.70 | |
| Steadymed | 0.1 | $8.0M | 3.1M | 2.60 | |
| Crispr Therapeutics (CRSP) | 0.1 | $7.5M | 372k | 20.26 | |
| Fluidigm Corporation convertible cor | 0.1 | $7.0M | 10M | 0.70 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $7.4M | 7.0M | 1.05 | |
| Tesaro | 0.1 | $6.3M | 47k | 134.47 | |
| Redhill Biopharma Ltd cmn | 0.1 | $5.9M | 565k | 10.46 | |
| Minerva Neurosciences | 0.1 | $6.5M | 556k | 11.75 | |
| Affimed Therapeutics B V | 0.1 | $6.1M | 3.4M | 1.80 | |
| Sientra | 0.1 | $6.3M | 743k | 8.52 | |
| Cellectis S A (CLLS) | 0.1 | $5.9M | 350k | 16.95 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $6.0M | 8.0M | 0.75 | |
| Aeglea Biotherapeutics | 0.1 | $5.9M | 1.4M | 4.35 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $5.4M | 757k | 7.17 | |
| Zimmer Holdings (ZBH) | 0.1 | $5.1M | 49k | 103.20 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $4.4M | 3.3M | 1.35 | |
| Invitae (NVTAQ) | 0.1 | $3.6M | 457k | 7.94 | |
| Roka Bioscience | 0.1 | $3.8M | 894k | 4.24 | |
| Amedisys (AMED) | 0.0 | $3.0M | 72k | 42.63 | |
| Valeant Pharmaceuticals Int | 0.0 | $2.8M | 195k | 14.52 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $2.9M | 724k | 4.05 | |
| Sangamo Biosciences (SGMO) | 0.0 | $2.2M | 707k | 3.05 | |
| Ptc Therapeutics I (PTCT) | 0.0 | $2.2M | 204k | 10.91 | |
| Clearside Biomedical (CLSD) | 0.0 | $2.7M | 300k | 8.94 | |
| Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $1.5M | 5.2M | 0.28 | |
| Amarin Corporation | 0.0 | $1.1M | 350k | 3.08 | |
| Biolinerx Ltd-spons | 0.0 | $956k | 1.0M | 0.92 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $560k | 500k | 1.12 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $590k | 500k | 1.18 | |
| Marinus Pharmaceuticals | 0.0 | $573k | 568k | 1.01 | |
| Noveliontherapeuti.. | 0.0 | $842k | 100k | 8.42 | |
| Alimera Sciences | 0.0 | $270k | 250k | 1.08 | |
| Xtant Med Holdings | 0.0 | $262k | 475k | 0.55 | |
| Medigus | 0.0 | $336k | 600k | 0.56 | |
| Aralez Pharmaceuticals | 0.0 | $301k | 68k | 4.42 |
